Malcolm Sacco

Malcolm Sacco has recently been appointed Head of Research and Development at Medichem, a pharmaceutical company specialising in the development and manufacture of Active Pharmaceutical Ingredient (APIs) and Finished Dosage Forms (FDFs) for the global generics industry.

At the start of his career, Mr Sacco worked at Medichem for over seven years, beginning as a Quality Control Laboratory Analyst in 2011 and later serving as a Research and Development Officer. In 2018, he left Medichem to gain experience with Siegfried Holding AG and A2W Pharma.

In 2020, Mr Sacco rejoined Medichem as an FDF Industrialisation Manager.

In his new role, Mr Sacco will be managing technology transfer, overseeing development projects, and providing scientific guidance. He will also lead a team of scientists, manage laboratories, and evaluate manufacturing opportunities.

Featured Image:

Facebook and Linkedin / Malcolm Sacco

Related

What survives February matters more than what starts in January

2 February 2026
by MaltaCEOs

How many goals or resolutions did you set in January?

Human-first leadership means backing personal goals, not just performance targets

27 January 2026
by MaltaCEOs

Supporting personal ambitions outside work is not a soft perk, but a strategic advantage.

Global CEO confidence hits five-year low as AI returns lag – but Maltese leaders signal resilience

23 January 2026
by Nicole Zammit

The question is whether Malta’s resilience today could mask the need for faster transformation tomorrow.

Why cheap wine is dying, but knowledge is thriving

23 January 2026
by MaltaCEOs

Cheap, commercial wines are taking the hardest hit.